• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SCITON INC. BBLS; POWERED LASER SURGICAL INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SCITON INC. BBLS; POWERED LASER SURGICAL INSTRUMENT Back to Search Results
Model Number BBLS
Medical Device Problem Code Use of Device Problem (1670)
Health Effect - Clinical Code Blister (4537)
Date of Event 03/29/2024
Type of Reportable Event Serious Injury
Event or Problem Description
On apr 23, 2024, the following information was reported by the clinic to sciton clinical specialist: patient information: age: 45 nationality: japanese skin type: iv initial visit (no prior cosmetic procedures).Medical history: past medical history: none present illness: none treatment was performed on (b)(6) 2024: bbl treatment was administered by the physician for overall facial rejuvenation and improvement of pigmentation.590nm, 8j, 20msec, 15°c, 15×45 - full face (large area), 1 pass, 60 shots 590nm, 10j, 20msec, 15°c, 15×15 - full face (small area), 1 pass, 40 shots 515nm, 15j, 10msec, 20°c, 7mm - spot treatment for pigmentation, 60 shots.Treatment started from the right side, with slight heat felt on the left side.No complaints of pain or heat sensation during the procedure, but patient reported flushing and tingling sensations post-procedure.Following the bbl treatment, iontophoresis (vitamin c) was administered.Subsequently, the patient reported blister formation during face washing (between the left nose and cheekbone).It was reported that the treatment included cooling, application of desonide cream on the left side and lindane cream (betamethasone valerate gentamicin sulfate) on the right side, blister drainage, and protection with mepilex dressing.Prescriptions included lindane cream (betamethasone valerate gentamicin sulfate), azunol (dimethyl isopropylazulene), vitamin c, tranexamic acid (tranexamic acid), and yubera (tocopherol acetate).Patient did not return for follow-up appointments as patient travelled abroad.
 
Additional Manufacturer Narrative
On april 19th, 2024, sciton field service engineer checked the device and reported the following: it was found that the sapphire block on the handpiece (s/n (b)(6) manufactured feb 2018) was loose and pushed in during use by the doctor.Upon inspection of the bbl hp the sapphire block had multiple chips on the interior side.The damage to the sapphire indicates that the handpiece may have been dropped causing the sapphire block to be loose and pushed in.Fse has inspected the system and there are no issues with the system other than the broken handpiece.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BBLS
Common Device Name
POWERED LASER SURGICAL INSTRUMENT
Manufacturer (Section D)
SCITON INC.
925 commercial street
palo alto CA 94303
Manufacturer (Section G)
SCITON INC.
925 commercial street
palo alto CA 94303
Manufacturer Contact
jay patel
925 commercial street
palo alto, CA 94303
6504939155
MDR Report Key19367980
Report Number2953696-2024-00036
Device Sequence Number7618432
Product Code GEX
UDI-Device Identifier00863249000312
UDI-Public0863249000312
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K101916
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBBLS
Device Catalogue Number1500-113-30
Device Lot Number30965
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/23/2024
Initial Report FDA Received Date05/21/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age45 YR
Patient SexUnknown
Patient RaceAsian
-
-